Evidence map›Paper›PMID 34150524›Full record

ArticleToxicology reports2021

Exploitation of traditional healing properties, using the nanotechnology's advantages: The case of curcumin.

Angeliki Liakopoulou, Elena Mourelatou, Sophia Hatziantoniou

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Dihydromyricetin-LoadedPharmaceutics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Encapsulation of MicroalgaeMarine drugs · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Angeliki LiakopoulouLaboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504, Patras, Greece.
Elena MourelatouLaboratory of Pharmaceutical Technology, Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 46 Makedonitissas Avenue, CY-2417, P.O. Box 24005, CY-1700, Nicosia, Cyprus.
Sophia HatziantoniouLaboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, 26504, Patras, Greece.
University of Patras · GRUniversity of Nicosia · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin (CUR) has a long history of use as an antimicrobial, anti-inflammatory and wound healing agent, for the treatment of various skin conditions. Encapsulation in nanocarriers may overcome the administration limitations of CUR, such as lipophilicity and photodegradation. Lipid nanocarriers with different matrix fluidity (Solid Lipid Nanoparticles; SLN, Nanostructured Lipid Carriers; NLC, and Nanoemulsion; NE) were prepared for the topical delivery of curcumin (CUR). The occlusive properties and film forming capacity, as well as the release profile of incorporated CUR, its protection against photodegradation and wound healing were studied

Indexed as

BSA, bovine serum albuminCA, cellulose acetateCurcuminCUR, curcuminDLS, Dynamic Light ScatteringDMEM, Dulbecco’s modified eagle mediumDMSO, dimethyl sulfoxideDPBS, Dulbecco’s phosphate buffered salineELS, Electrophoretic Light ScatteringEtOH, ethanolFBS, fetal bovine serumMeOH, methanolNanoemulsionNanostructured lipid carrierNE, nanoemulsionNLC, nanostructured lipid carriersOcclusionPBS, phosphate buffered salinePdI, polydispersity indexP/S, penicillin/streptomycinRH, relative humidityRT, room temperatureSD, standard deviationSEM, scanning electron microscopySLN, solid lipid nanoparticlesSolid lipid nanoparticleTG, triglycerideTopical applicationUV-VIS, ultraviolet – visible spectrophotometryWFI, water for injectionWound healing

Identifiers

PMID34150524
PMCPMC8190487
OpenAlexW3166250077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.